Safety and outcomes of intensity modulated proton therapy in patients with non small cell lung cancer with interstitial lung disease. - Roden RT; Harmsen WS; Breen WG; Moffett JN; Pulsipher SD; Olivier KR; Garces YI; Park SS; Merrell KW; Sarkaria JN; Owen D (Lung cancer (Amsterdam, Netherlands), 2025)